XML 17 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company has two operating segments for which it recognizes revenue; Clinical Services and Pharma Services. Our Clinical Services segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. Our Pharma Services segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research.

The financial information reviewed by the Chief Operating Decision Maker (“CODM”) includes revenues, cost of revenue and gross margin for each of the Company’s operating segments. Assets are not presented at the segment level as that information is not used by the CODM.  

The following table summarizes the segment information (in thousands):   

Three Months Ended September 30,Nine Months Ended September 30,
2019201820192018
Net revenues:
Clinical Services$92,565  $59,449  $267,757  $175,960  
Pharma Services12,107  9,647  34,205  24,306  
Total Revenue104,672  69,096  301,962  200,266  
Cost of revenue:
Clinical Services47,526  31,509  136,557  94,586  
Pharma Services6,314  5,266  18,492  15,525  
Total Cost of Revenue53,840  36,775  155,049  110,111  
Gross Profit:
Clinical Services45,039  27,940  131,200  81,374  
Pharma Services5,793  4,381  15,713  8,781  
Total Gross Profit50,832  32,321  146,913  90,155  
Operating expenses:
General and administrative33,054  21,055  94,773  59,106  
Research and development2,611  446  6,407  2,475  
Sales and marketing11,508  6,900  35,048  21,355  
Total operating expenses47,173  28,401  136,228  82,936  
Income from Operations3,659  3,920  10,685  7,219  
Interest expense, net203  1,873  3,333  4,766  
Other (income) expense(35) (30) 5,124  31  
Loss on extinguishment of debt—  —  1,018  —  
Income before taxes3,491  2,077  1,210  2,422  
Income tax expense (benefit)1,348  54  (500) 135  
Net income$2,143  $2,023  $1,710  $2,287